Ads
related to: Fda and Paclitaxel
Search results
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Benzinga via AOL· 6 days agoThe initial interim results will be presented at the upcoming American Society of Clinical Oncology...
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena via Yahoo Finance· 6 days agoVerastem stated the dose cohort was cleared after additional patients were evaluated. Avutometinib...
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
CBS 47 Fresno· 6 days agoUSA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment advancements, particularly ...
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and...
FOX 23 News Albany· 6 days agoOne is a trial-in-progress abstract discussing cohort 5 of the GOBLET study, which will evaluate the combination of pelareorep and modified FOLFIRINOX (mFOLFIRINOX) with & ...
TME Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders
Morningstar· 4 days agoThe annual accounts for the year ending December 31, 2023, and the report of the board of directors for 2023, the convocation to the AGM, the agenda and ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 1 day agoSixteen Researchers from Florida Cancer Specialists & Research Institute Share Cancer Care Discoveries at 2024 ASCO® Annual Meeting PR Newswire FORT MYERS, Fla., May 29, 2024 37 Cutting-Edge Study Results Presented at Global Gathering, Six Oral
